Adverse drug reactions in the elderly

被引:77
作者
Brahma, Dhriti K. [1 ]
Wahlang, Julie B. [1 ]
Marak, Maxilline D. [1 ]
Sangma, Marlina Ch. [1 ]
机构
[1] North Eastern Indira Gandhi Reg Inst Hlth & Med S, Dept Pharmacol, Shillong, Meghalaya, India
关键词
Polypharmacy; elderly; drug safety data;
D O I
10.4103/0976-500X.110872
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Medications probably are the single most important health care technology in preventing illness, disability, and death in the geriatric population. Age-related changes in drug disposition and pharmacodynamic responses have significant clinical implications; increased use of a number of medications raises the risk that medicinerelated problems may occur. The relationship between increased use of drugs including the prescription medication and elderly is well established. Majority of ADRs (80%) causing admission or occurring in hospital are type A reactions. Although less common occurring in elderly, type B ADRs may sometimes cause serious toxicity. Studies have correlated the integral association between old age and increased rate of adverse drug reactions arising out of confounding association between age and polypharmacy contributed by agerelated changes in pharmacodynamics and pharmacokinetics at least for some medical conditions. A drug combination may sometimes cause synergistic toxicity which is greater than the sum of the risks of toxicity of either agent used alone. But, strategies to increase opportunities for identifying ADRs and related problems have not been emphasised in current international policy responses especially in India to the increase in elderly population and chronic conditions. Careful epidemiological studies that encompass large numbers of elderly drug users are required to obtain this information as increased knowledge of the frequency and cost of adverse drug reactions is important in enabling both more rational therapeutic decisions by individual clinicians and more optimal social policy.
引用
收藏
页码:91 / 94
页数:4
相关论文
共 19 条
[1]
[Anonymous], WORLD POPULATION AGE
[2]
The epidemiology of serious adverse drug reactions among the elderly [J].
Atkin, PA ;
Veitch, PC ;
Veitch, EM ;
Ogle, SJ .
DRUGS & AGING, 1999, 14 (02) :141-152
[3]
MEDICATION USE AND THE ELDERLY - CURRENT STATUS AND OPPORTUNITIES [J].
AVORN, J .
HEALTH AFFAIRS, 1995, 14 (01) :276-286
[4]
Bowman Lee, 1996, Pharmacoepidemiology and Drug Safety, V5, P9, DOI 10.1002/(SICI)1099-1557(199601)5:1<9::AID-PDS192>3.3.CO
[5]
2-U
[6]
IS AGE AN INDEPENDENT RISK FACTOR OF ADVERSE DRUG-REACTIONS IN HOSPITALIZED MEDICAL PATIENTS [J].
CARBONIN, P ;
PAHOR, M ;
BERNABEI, R ;
SGADARI, A .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1991, 39 (11) :1093-1099
[7]
NONSTEROIDAL ANTIINFLAMMATORY DRUG-USE AND INCREASED RISK FOR PEPTIC-ULCER DISEASE IN ELDERLY PERSONS [J].
GRIFFIN, MR ;
PIPER, JM ;
DAUGHERTY, JR ;
SNOWDEN, M ;
RAY, WA .
ANNALS OF INTERNAL MEDICINE, 1991, 114 (04) :257-263
[8]
THE AMBIGUOUS RELATION BETWEEN AGING AND ADVERSE DRUG-REACTIONS [J].
GURWITZ, JH ;
AVORN, J .
ANNALS OF INTERNAL MEDICINE, 1991, 114 (11) :956-966
[9]
Hamilton RA, 1998, PHARMACOTHERAPY, V18, P1112
[10]
Frequency and nature of adverse drug reactions in elderly in-patients of two Indian medical college hospitals [J].
Harugeri, A. ;
Parthasarathi, G. ;
Ramesh, M. ;
Guido, S. ;
Basavanagowdappa, H. .
JOURNAL OF POSTGRADUATE MEDICINE, 2011, 57 (03) :189-195